In a recent clinical study conducted with Flicker Glass™, results showed significant improvement in both visual acuity and stereopsis – even into older age ranges typically considered more challenging to treat. Study investigators were impressed with the remarkable levels of compliance, and patients and parents rated Flicker Glass™ highly on ease of use, comfort, and preference over traditional monocular therapies. From a quality of life perspective, reports of improved reading and sports performance supported the overall positive evaluation of this novel Flicker Glass™ experience.
Data presented at scientific meetings this year has been well received by the eye care and vision science communities, including academic researchers, private practice optometrists and vision therapists, and pediatric ophthalmologists. Ongoing clinical evaluation is in progress to further advance Flicker Glass™ binocular therapy
A recent study published in the Vision Development and Rehabilitation Journal (Volume 2, Issue 2 - July 2016), "A Flicker Therapy for Treatment of Amblyopia - (click to read)
" found that after 12 weeks of therapy, 96% of the children treated improved their best-corrected LogMAR visual acuity in the amblyopic eye (p<0.001) and over 26% improved 2 LogMar lines or more (fellow eye best-corrected LogMAR visual acuity did not change) and 89% of the children with reliable data improved global stereopsis.